Metropolis Healthcare Sets Record Date for 3:1 Bonus Share Issue and SEBI-Outlined Allotment Timeline

Metropolis Healthcare Limited set a record date for issuing bonus equity shares. The Mumbai-based diagnostics firm disclosed the corporate action through an exchange filing. The move followed earlier board and shareholder steps. Investors tracked the update as the stock traded lower on the NSE during the latest session.

Metropolis Healthcare Ltd. (METROPOLIS) last traded on March 13, 2026 at Rs 1,810.00. The price fell 0.76% versus the previous close. The session opened at Rs 1,825.00. The stock touched Rs 1,835.00 intraday and slipped to Rs 1,801.00.

"This is in reference to our previous intimations dated February 04, 2026, and March 09, 2026, regarding the recommendation of the Board of Directors of the Company and subsequent approval of the shareholders (via Postal Ballot) of the Company, for the issuance of Bonus Equity Shares in the ratio of 3:1, i.e., Three (3) new fully paid-up Equity Shares of face value of INR 2/- (Indian Rupees Two only) each for every One (1) existing fully paid-up Equity Share of face value of INR 2/- (Indian Rupees Two only) each," said Metropolis Healthcare in a stock exchange filing.

The Board of Directors acted through a circular resolution on March 10, 2026. It fixed Friday, March 20, 2026 as the record date. The date will decide which equity shareholders qualify for the 3:1 bonus issue. The company also shared an expected timeline for allotment under SEBI rules.

"Further, in accordance with SEBI Circular No. CIR/CFD/PoD/2024/122 dated September 16, 2024, the deemed date of allotment of Bonus Equity Shares shall be Monday, March 23, 2026," Metropolis Healthcare has further informed stock exchanges.

Over the last year, Metropolis Healthcare delivered a return of nearly 11.89%. The price stayed within a 52-week band of Rs 1,315.00 to Rs 2,263.00. The latest trading range and the longer band are summarised below for quick reference by finance readers.

Metric	Value
Last traded price (NSE)	Rs 1,810.00
Change	-0.76%
Open	Rs 1,825.00
Intraday high	Rs 1,835.00
Intraday low	Rs 1,801.00
52-week low	Rs 1,315.00
52-week high	Rs 2,263.00
1-year return	~11.89%

"Investors who prefer accumulating at lower levels can always opt to pick Metropolis Healthcare at these levels, as the company has a very strong medical diagnostic business model. Metropolis Healthcare, running in a downward falling channel, has formed a good double bottom on the level of Rs. 1745-1750 while in a continuous downtrend, with RSI below 40 and running below major moving averages. Although in a downtrend, it may give a good bounce up to Rs. 1960. Buying at Rs. 1800 - 1810 with stop loss of Rs.1725 and target of Rs. 1950 seems to be a good trade now," commented Market Wizard's Adib Noorani.

Metropolis Healthcare business profile

Metropolis Healthcare Limited was founded in 1981 and is India’s second-largest diagnostic chain. The company provides diagnostic services across India and Africa. It reported a network of 219 laboratories and over 4,800 patient service settings. It also listed more than 10,000 touchpoints across 28 states and 7 Union Territories.

Its presence extended to more than 750 towns in India, based on the disclosure. Separately, readers should note a standard publishing disclaimer. Disclaimer: The views and recommendations expressed are solely those of the individual analysts or entities and do not reflect the views of Goodreturns.in or Greynium Information Technologies Private Limited (together referred to as "we"). We do not guarantee, endorse or take responsibility for the accuracy, completeness or reliability of any content, nor do we provide any investment advice or solicit the purchase or sale of securities. All information is provided for informational and educational purposes only and should be independently verified from licensed financial advisors before making any investment decisions.